Novavax inks deal to supply 76M doses of COVID-19 vaccine to Canada

Novavax (NASDAQ:NVAX) has reached an agreement in principle with the Canadian government to supply up to 76M doses of COVID-19 vaccine, NVX-CoV2373, if approved.

Shipments may start as early as Q2 2021, subject to licensure.

The advance purchase agreement should be finalized shortly.

https://seekingalpha.com/news/3610077-novavax-inks-deal-to-supply-76m-doses-of-covidminus-19-vaccine-to-canada